BlackRock Price To Sales Ratio vs Pocfratio Analysis

BSTZ Stock

USD 21.32 0.21 0.98%

BlackRock Science financial indicator trend analysis is way more than just evaluating BlackRock Science prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BlackRock Science is a good investment. Please check the relationship between BlackRock Science Price To Sales Ratio and its Pocfratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BlackRock Science and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Price To Sales Ratio vs Pocfratio

Price To Sales Ratio vs Pocfratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BlackRock Science Price To Sales Ratio account and Pocfratio. At this time, the significance of the direction appears to have very week relationship.

The correlation between BlackRock Science's Price To Sales Ratio and Pocfratio is 0.29. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Pocfratio in the same time period over historical financial statements of BlackRock Science and, assuming nothing else is changed. The correlation between historical values of BlackRock Science's Price To Sales Ratio and Pocfratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of BlackRock Science and are associated (or correlated) with its Pocfratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pocfratio has no effect on the direction of Price To Sales Ratio i.e., BlackRock Science's Price To Sales Ratio and Pocfratio go up and down completely randomly.

Correlation Coefficient

0.29

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing BlackRock Science stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BlackRock Science sales, a figure that is much harder to manipulate than other BlackRock Science and multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Pocfratio

Most indicators from BlackRock Science's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BlackRock Science current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BlackRock Science and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

At this time, BlackRock Science's Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 4.51 in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0 in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	2.2M	1.8M	282.2M	296.3M
Cost Of Revenue	41.2M	25.9M	20.4M	27.2M

Total Operating Expenses Cost Of Revenue

BlackRock Science fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments
Total Assets		-0.5	-0.2	0.23	1.0	0.18	0.96	-0.4	-0.26	1.0	-1.0	-0.15	0.13	-0.19	-0.3	0.09	0.08	-0.41	0.13	-0.25	0.13	-0.5	0.44	0.13	0.28	1.0
Short Long Term Debt Total	-0.5		0.88	-0.86	-0.55	-0.89	-0.72	-0.17	-0.39	-0.5	0.49	-0.56	0.53	-0.5	-0.63	0.57	0.41	0.99	0.53	0.93	0.53	0.99	-0.99	0.53	-0.83	-0.5
Other Current Liab	-0.2	0.88		-0.98	-0.25	-0.82	-0.44	-0.17	-0.51	-0.2	0.19	-0.62	0.6	-0.58	-0.75	0.63	0.48	0.87	0.6	0.96	0.6	0.83	-0.86	0.6	-0.96	-0.2
Total Current Liabilities	0.23	-0.86	-0.98		0.28	0.75	0.45	0.16	0.38	0.23	-0.23	0.51	-0.43	0.46	0.76	-0.48	-0.28	-0.83	-0.43	-0.96	-0.43	-0.83	0.83	-0.43	0.98	0.23
Total Stockholder Equity	1.0	-0.55	-0.25	0.28		0.23	0.97	-0.38	-0.23	1.0	-1.0	-0.11	0.09	-0.16	-0.25	0.05	0.06	-0.46	0.09	-0.3	0.09	-0.55	0.49	0.09	0.33	1.0
Net Debt	0.18	-0.89	-0.82	0.75	0.23		0.46	0.14	0.75	0.18	-0.17	0.86	-0.82	0.83	0.69	-0.85	-0.66	-0.94	-0.82	-0.84	-0.82	-0.88	0.93	-0.82	0.74	0.18
Retained Earnings	0.96	-0.72	-0.44	0.45	0.97	0.46		-0.33	-0.01	0.96	-0.95	0.13	-0.14	0.08	-0.06	-0.18	-0.14	-0.65	-0.14	-0.48	-0.14	-0.71	0.68	-0.14	0.49	0.96
Accounts Payable	-0.4	-0.17	-0.17	0.16	-0.38	0.14	-0.33		-0.14	-0.41	0.41	-0.07	0.01	-0.1	0.63	0.0	-0.04	-0.21	0.01	-0.32	0.01	-0.2	0.19	0.01	-0.04	-0.41
Cash	-0.26	-0.39	-0.51	0.38	-0.23	0.75	-0.01	-0.14		-0.26	0.28	0.98	-0.93	0.99	0.43	-0.93	-0.78	-0.48	-0.93	-0.39	-0.93	-0.35	0.47	-0.93	0.46	-0.26
Non Current Assets Total	1.0	-0.5	-0.2	0.23	1.0	0.18	0.96	-0.41	-0.26		-1.0	-0.15	0.13	-0.19	-0.3	0.09	0.08	-0.41	0.13	-0.25	0.13	-0.5	0.44	0.13	0.28	1.0
Non Currrent Assets Other	-1.0	0.49	0.19	-0.23	-1.0	-0.17	-0.95	0.41	0.28	-1.0		0.16	-0.14	0.21	0.3	-0.11	-0.1	0.4	-0.14	0.24	-0.14	0.49	-0.43	-0.14	-0.28	-1.0
Other Assets	-0.15	-0.56	-0.62	0.51	-0.11	0.86	0.13	-0.07	0.98	-0.15	0.16		-0.95	1.0	0.53	-0.95	-0.79	-0.64	-0.95	-0.54	-0.95	-0.52	0.63	-0.95	0.56	-0.14
Long Term Debt	0.13	0.53	0.6	-0.43	0.09	-0.82	-0.14	0.01	-0.93	0.13	-0.14	-0.95		-0.95	-0.43	1.0	0.94	0.6	1.0	0.49	1.0	0.47	-0.59	1.0	-0.48	0.12
Cash And Short Term Investments	-0.19	-0.5	-0.58	0.46	-0.16	0.83	0.08	-0.1	0.99	-0.19	0.21	1.0	-0.95		0.5	-0.95	-0.79	-0.59	-0.95	-0.49	-0.95	-0.46	0.57	-0.95	0.53	-0.19
Net Receivables	-0.3	-0.63	-0.75	0.76	-0.25	0.69	-0.06	0.63	0.43	-0.3	0.3	0.53	-0.43	0.5		-0.46	-0.25	-0.68	-0.43	-0.82	-0.43	-0.65	0.66	-0.43	0.65	-0.3
Common Stock Total Equity	0.09	0.57	0.63	-0.48	0.05	-0.85	-0.18	0.0	-0.93	0.09	-0.11	-0.95	1.0	-0.95	-0.46		0.93	0.65	1.0	0.54	1.0	0.52	-0.64	1.0	-0.52	0.09
Common Stock Shares Outstanding	0.08	0.41	0.48	-0.28	0.06	-0.66	-0.14	-0.04	-0.78	0.08	-0.1	-0.79	0.94	-0.79	-0.25	0.93		0.48	0.94	0.36	0.94	0.34	-0.47	0.94	-0.32	0.08
Short Term Investments	-0.41	0.99	0.87	-0.83	-0.46	-0.94	-0.65	-0.21	-0.48	-0.41	0.4	-0.64	0.6	-0.59	-0.68	0.65	0.48		0.6	0.93	0.6	0.99	-1.0	0.6	-0.8	-0.41
Long Term Debt Total	0.13	0.53	0.6	-0.43	0.09	-0.82	-0.14	0.01	-0.93	0.13	-0.14	-0.95	1.0	-0.95	-0.43	1.0	0.94	0.6		0.49	1.0	0.47	-0.59	1.0	-0.48	0.12
Non Current Liabilities Total	-0.25	0.93	0.96	-0.96	-0.3	-0.84	-0.48	-0.32	-0.39	-0.25	0.24	-0.54	0.49	-0.49	-0.82	0.54	0.36	0.93	0.49		0.49	0.92	-0.92	0.49	-0.91	-0.25
Capital Surpluse	0.13	0.53	0.6	-0.43	0.09	-0.82	-0.14	0.01	-0.93	0.13	-0.14	-0.95	1.0	-0.95	-0.43	1.0	0.94	0.6	1.0	0.49		0.47	-0.59	1.0	-0.48	0.12
Inventory	-0.5	0.99	0.83	-0.83	-0.55	-0.88	-0.71	-0.2	-0.35	-0.5	0.49	-0.52	0.47	-0.46	-0.65	0.52	0.34	0.99	0.47	0.92	0.47		-0.99	0.47	-0.79	-0.5
Other Current Assets	0.44	-0.99	-0.86	0.83	0.49	0.93	0.68	0.19	0.47	0.44	-0.43	0.63	-0.59	0.57	0.66	-0.64	-0.47	-1.0	-0.59	-0.92	-0.59	-0.99		-0.59	0.8	0.44
Other Stockholder Equity	0.13	0.53	0.6	-0.43	0.09	-0.82	-0.14	0.01	-0.93	0.13	-0.14	-0.95	1.0	-0.95	-0.43	1.0	0.94	0.6	1.0	0.49	1.0	0.47	-0.59		-0.48	0.12
Total Liab	0.28	-0.83	-0.96	0.98	0.33	0.74	0.49	-0.04	0.46	0.28	-0.28	0.56	-0.48	0.53	0.65	-0.52	-0.32	-0.8	-0.48	-0.91	-0.48	-0.79	0.8	-0.48		0.28
Long Term Investments	1.0	-0.5	-0.2	0.23	1.0	0.18	0.96	-0.41	-0.26	1.0	-1.0	-0.14	0.12	-0.19	-0.3	0.09	0.08	-0.41	0.12	-0.25	0.12	-0.5	0.44	0.12	0.28

Click cells to compare fundamentals

BlackRock Science Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for BlackRock Stock Analysis

When running BlackRock Science's price analysis, check to measure BlackRock Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BlackRock Science is operating at the current time. Most of BlackRock Science's value examination focuses on studying past and present price action to predict the probability of BlackRock Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BlackRock Science's price. Additionally, you may evaluate how the addition of BlackRock Science to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BlackRock Price To Sales Ratio vs Pocfratio Analysis

Price To Sales Ratio vs Pocfratio

Price To Sales Ratio vs Pocfratio Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Pocfratio

BlackRock Science fundamental ratios Correlations

BlackRock Science Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for BlackRock Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Long Term Investments	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Stockholder Equity
Long Term Investments	+ 1.0	Total Stockholder Equity
Long Term Investments	+ 1.0	Non Current Assets Total

Other Current Assets	- 1.0	Short Term Investments
Long Term Investments	- 1.0	Non Currrent Assets Other
Non Currrent Assets Other	- 1.0	Non Current Assets Total
Non Currrent Assets Other	- 1.0	Total Stockholder Equity
Non Currrent Assets Other	- 1.0	Total Assets
Other Current Assets	- 0.99	Inventory